shutterstock

“Extremely promising” blood test for autism impresses with 88% accuracy

June 20, 2018
Research and Development autism, pharma

A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been …

Pharma on Facebook

Facebook unveils new feature to battle opioid crisis

June 20, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …

FDA places hold on Ziopharm CAR-T trial

June 19, 2018
Manufacturing and Production, Research and Development CAR-T, FDA, pharma, ziopharm

CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …

ptc

PTC Therapeutics’ results in SMA has Biogen nervous

June 19, 2018
Manufacturing and Production, Research and Development Biogen, PTC Therapeutics, biotech, drugs, pharma, pharmaceutical

Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …

valeant_web

FDA rejects Valeant plaque psoriasis lotion over pharmacokinetic concerns

June 19, 2018
Manufacturing and Production, Sales and Marketing FDA, Valeant, pharma, psoriasis

Beleaguered pharma firm Valeant has come up against another bump in the road as its plaque psoriasis lotion Duobrii (halobetasol …

roche__tree

Roche buys out rest of Foundation Medicine for $2.4bn

June 19, 2018
Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …

8659041633_851995ca6c_z

Theranos founder charged with fraud

June 18, 2018
Manufacturing and Production, Medical Communications Theranos, biotech, drugs, pharma, pharmaceutical

Going from the youngest female self-made billionaire in the world to being charged with engaging in schemes to defraud investors …

facilities_lg06

Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute

June 18, 2018
Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone

Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …

data

Maintaining control: The rising challenges of clinical data management

June 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …

vaccination-2722937_960_720_1

HPV vaccine slashes rate of infection by 86% in UK

June 18, 2018
Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination

Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …

teva_copy

Teva axes Phase 3 trial into chronic cluster headache

June 18, 2018
Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …

opdivo_1_1

BMS’ Opdivo becomes first immuno-oncology agent available in China

June 18, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …

theresa_may_-_arno_mikkor

£20bn promised to NHS but questions over where money will come from

June 18, 2018
Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical

Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …

top_ten

Top Ten most popular articles on Pharmafile.com this week

June 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …

allergan

Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …

New Jersey attempts to lure Teva HQ with tax incentives

June 15, 2018
Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …

rocherooflr

NICE turns down Roche’s Perjeta for post-surgery HER2-positive breast cancer

June 15, 2018
Medical Communications, Sales and Marketing Cancer, NICE, Perjeta, Roche, breast cancer, pharma

Roche’s ongoing dispute with UK health service watchdog NICE over the availability of its monoclonal antibody Perjeta (pertuzumab) on the …

wheelchair-1595802_960_720

Gene therapy offers hope for those with paralysis

June 15, 2018
Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical

Researchers at King’s College London (KCL) have made significant progress to being able to offer a treatment to those with …

Living with childhood dementia

June 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma

Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …

roche

Roche’s Ocrevus extends time-to-wheelchair by 7 years in progressive MS patients

June 14, 2018
Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has lifted the curtain on more promising data at Phase 3 for its humanised anti-CD20 monoclonal antibody Ocrevus (ocrelizumab), …

The Gateway to Local Adoption Series

Latest content